Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997 - PubMed (original) (raw)
. 1997 Aug 22;46(33):765-6.
- PMID: 9272582
Free article
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997.
Free article
Erratum in
- MMWR Morb Mortal Wkly Rep 1997 Sep 12;46(36):851
Abstract
Staphylococcus aureus is one of the most common causes of both hospital- and community-acquired infections worldwide, and the antimicrobial agent vancomycin has been used to treat many S. aureus infections, particularly those caused by methicillin-resistant S. aureus (MRSA). In 1996, the first documented case of infection caused by a strain of S. aureus with intermediate levels of resistance to vancomycin (VISA; minimum inhibitory concentration [MIC]=8 microg/mL) was reported from Japan. This report describes the first isolation of VISA from a patient in the United States, which may be an early warning that S. aureus strains with full resistance to vancomycin will emerge.
Similar articles
- Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997 Sep 5;46(35):813-5. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9310213 - Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7. MMWR Morb Mortal Wkly Rep. 2000. PMID: 11266244 - Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. Smith TL, et al. N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701. N Engl J Med. 1999. PMID: 10021469 - Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC. Appelbaum PC. Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20. Int J Antimicrob Agents. 2007. PMID: 17888634 Review. - Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
Fridkin SK. Fridkin SK. Clin Infect Dis. 2001 Jan;32(1):108-15. doi: 10.1086/317542. Epub 2000 Dec 13. Clin Infect Dis. 2001. PMID: 11118389 Review.
Cited by
- Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
Backo M, Gaenger E, Burkart A, Chai YL, Bayer AS. Backo M, et al. Antimicrob Agents Chemother. 1999 Oct;43(10):2565-8. doi: 10.1128/AAC.43.10.2565. Antimicrob Agents Chemother. 1999. PMID: 10508047 Free PMC article. - Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.
Verdier I, Reverdy ME, Etienne J, Lina G, Bes M, Vandenesch F. Verdier I, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):1024-7. doi: 10.1128/AAC.48.3.1024-1027.2004. Antimicrob Agents Chemother. 2004. PMID: 14982800 Free PMC article. - Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients.
Bert F, Clarissou J, Durand F, Delefosse D, Chauvet C, Lefebvre P, Lambert N, Branger C. Bert F, et al. J Clin Microbiol. 2003 Nov;41(11):5147-52. doi: 10.1128/JCM.41.11.5147-5152.2003. J Clin Microbiol. 2003. PMID: 14605151 Free PMC article. - Positive blood cultures for coagulase-negative staphylococci in neonates: does highly selective vancomycin usage affect outcome?
Matrai-Kovalskis Y, Greenberg D, Shinwell ES, Fraser D, Dagan R. Matrai-Kovalskis Y, et al. Infection. 1998 Mar-Apr;26(2):85-92. doi: 10.1007/BF02767766. Infection. 1998. PMID: 9561377 - Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK, Sen MR. Tiwari HK, et al. BMC Infect Dis. 2006 Oct 26;6:156. doi: 10.1186/1471-2334-6-156. BMC Infect Dis. 2006. PMID: 17067393 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous